Fed-batch strategies for intensified rVSV vector production in high cell density cultures of suspension HEK293 cells.
Autor: | Silva CAT; Department of Chemical Engineering, Polytechnique Montréal, Montreal, Quebec, Canada.; Department of Bioengineering, McGill University, Montreal, Quebec, Canada., Kamen AA; Department of Bioengineering, McGill University, Montreal, Quebec, Canada., Henry O; Department of Chemical Engineering, Polytechnique Montréal, Montreal, Quebec, Canada. |
---|---|
Jazyk: | angličtina |
Zdroj: | Biotechnology progress [Biotechnol Prog] 2024 Sep 17, pp. e3506. Date of Electronic Publication: 2024 Sep 17. |
DOI: | 10.1002/btpr.3506 |
Abstrakt: | Vesicular stomatitis virus (VSV) has been increasingly demonstrated as a promising viral vector platform. As the interest over this modality for vaccine and gene therapy applications increases, the need for intensified processes to produce these vectors emerge. In this study, we develop fed-batch-based operations to intensify the production of a recombinant VSV-based vaccine candidate (rVSV-SARS-CoV-2) in suspension cultures of HEK293 cells. A feeding strategy, in which a commercial concentrated medium was added to cultures based on cell growth through a fixed cell specific feeding rate (CSFR), was applied for the development of two different processes using Ambr250 modular bioreactors. Cultures operated in hybrid fed-batch/perfusion (FB/P) or fed-batch (FB) were able to sustain infections performed at 8.0 × 10 6 cells/mL, respectively resulting in 3.9 and 5.0-fold increase in total yield (Y (© 2024 The Author(s). Biotechnology Progress published by Wiley Periodicals LLC on behalf of American Institute of Chemical Engineers.) |
Databáze: | MEDLINE |
Externí odkaz: |